The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib, open-label trial of MOv18 IgE in patients with advanced ovarian cancer.
 
Rebecca Kristeleit
Honoraria - Abbvie; Abbvie; AstraZeneca; Basilea Pharmaceutical; Celcuity; Clovis Oncology; Eisai; Genmab; GlaxoSmithKline; Incyte; Leucid Bio; Merck Sharp & Dohme; MSD Oncology; Pharma&; Regeneron; Roche/Genentech; Shattuck Labs; Tesaro
Consulting or Advisory Role - Basilea; Clovis Oncology
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; MSD Oncology
 
Bristi Basu
No Relationships to Disclose
 
Rowan Miller
Consulting or Advisory Role - AZD; Clovis Oncology; Ellipses Pharma; GlaxoSmithKline; Merck KGaA; Roche
Speakers' Bureau - AZD; Clovis Oncology; GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Jose Iglesias
Consulting or Advisory Role - ALLARITY THERAPEUTICS; Amplia Therapeutics; Carina Biotech; DUO ONCOLOGY; Epsilogen; HIberCell; Panavance Therapeutics
 
Andrew Calam
No Relationships to Disclose
 
Rachel Nirsimloo
No Relationships to Disclose
 
Clare Green
No Relationships to Disclose
 
Axel Walther
Consulting or Advisory Role - Clovis Oncology; Regeneron
Speakers' Bureau - GlaxoSmithKline
 
Chris Twelves
No Relationships to Disclose
 
James Spicer
Leadership - APOBEC Discovery Ltd
Stock and Other Ownership Interests - Avacta Therapeutics; Epsilogen
Consulting or Advisory Role - AstraZeneca (Inst); BioNTch (Inst); Roche (Inst)
Research Funding - Achilles Therapeutics (Inst); AstraZeneca (Inst); BerGenBio (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); IO Biotech (Inst); MSD (Inst); Roche (Inst); RS Oncology (Inst); Starpharma (Inst); Tubulis GmbH (Inst)
Patents, Royalties, Other Intellectual Property - Use of IgE antibodies for treatment of cancer
Travel, Accommodations, Expenses - MSD; Starpharma